Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?-Reference-Cited by-同舟云学术

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

Published:2017-10 Issue:1 Volume:147 Page:85-91
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fader Amanda N.,Bergstrom Jennifer,Jernigan Amelia,Tanner Edward J.,Roche Kara Long,Stone Rebecca L.,Levinson Kimberly L.,Ricci Stephanie,Wethingon Stephanie,Wang Tian-Li,Shih Ie-Ming,Yang Bin,Zhang Gloria,Armstrong Deborah K.,Gaillard Stephanie,Michener Chad,DeBernardo Robert,Rose Peter G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference44 articles.

1. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study;Winter;J. Clin. Oncol.,2007

2. Grading ovarian serous carcinoma using a two-tier system;Malpica;Am. J. Surg. Pathol.,2004

3. Interobserver and Intraobserver variability of a two-tier system for grading ovarian serous carcinoma;Malpica;Am. J. Surg. Pathol.,2007

4. Coleman RL reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group study;Bodurka;Cancer,2012

5. Clinical behavior of stage II–IV low-grade serous carcinoma of the ovary;Gershenson;Obstet. Gynecol.,2006

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.;Gynecologic Oncology;2024-11

2. Steroid metabolism and hormonal dynamics in normal and malignant ovaries;Essays in Biochemistry;2024-07-12

3. Targeted Therapies in Low-Grade Serous Ovarian Cancers;Current Treatment Options in Oncology;2024-06-13

4. Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer;Gynecologic Oncology Reports;2024-06

5. Outcome and prognostic factors of low‑grade serous ovarian cancer: An observational retrospective study;Molecular and Clinical Oncology;2024-05-22